Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol

ClinicalTrials.gov ID: NCT06360419

Public ClinicalTrials.gov record NCT06360419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Trial of Solriamfetol in Subjects With Major Depressive Disorder

Study identification

NCT ID
NCT06360419
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
346 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Solriamfetol 300 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 17, 2024
Primary completion
Dec 30, 2024
Completion
Mar 25, 2025
Last update posted
Jan 4, 2026

2024 – 2025

United States locations

U.S. sites
40
U.S. states
18
U.S. cities
38
Facility City State ZIP Site status
Clinical Research Site Little Rock Arkansas 72211
Clinical Research Site Bellflower California 90706
Clinical Research Site Encino California 91316
Clinical Research Site Lemon Grove California 91945
Clinical Research Site Los Angeles California 90015
Clinical Research Site Montclair California 91763
Clinical Research Site Oceanside California 92056
Clinical Research Site Redlands California 92374
Clinical Research Site Riverside California 92506
Clinical Research Site Sherman Oaks California 91403
Clinical Research Site Torrance California 90501
Clinical Research Site Upland California 91786
Clinical Research Site Walnut Creek California 94596
Clinical Research Site Cromwell Connecticut 06416
Clinical Research Site Brandon Florida 33511
Clinical Research Site Hialeah Florida 33012
Clinical Research Site Jacksonville Florida 32256
Clinical Research Site Orlando Florida 32801
Clinical Research Site Orlando Florida 32806
Clinical Research Site Orlando Florida 32807
Clinical Research Site Chicago Illinois 60634
Clinical Research Site Overland Park Kansas 66210
Clinical Research Site New Orleans Louisiana 70115
Clinical Research Site Boston Massachusetts 02131
Clinical Research Site Saint Charles Missouri 63304
Clinical Research Site Las Vegas Nevada 89102
Clinical Research Site Brooklyn New York 11235
Clinical Research Site Rochester New York 14609
Clinical Research Site Staten Island New York 10314
Clinical Research Site Hickory North Carolina 28601
Clinical Research Site Cincinnati Ohio 45215
Clinical Research Site Oklahoma City Oklahoma 73116
Clinical Research Site Media Pennsylvania 19063
Clinical Research Site Philadelphia Pennsylvania 19104
Clinical Research Site Memphis Tennessee 38119
Clinical Research Site Austin Texas 78737
Clinical Research Site Dallas Texas 75231
Clinical Research Site Friendswood Texas 77546
Clinical Research Site Wichita Falls Texas 76309
Clinical Research Site Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06360419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 4, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06360419 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →